Riskpilot← Back to searchSign inGet full accessDr. Direkt Lallium AB
ABActiveOrg 5566524434Östra Hamngatan 52General medical practice activities · NACE 8621Est. 20031 employees
Revenue 2025
SEK 1,6M
+3% vs 2024
EBITDA margin
26.6%
+15% vs 2024
Equity ratio
62.0%
Financial strength
Net profit 2025
SEK 138K
-59% vs 2024
| Revenue | SEK 1,6M | +3% |
| EBITDA | SEK 438K | +15% |
| Net profit | SEK 138K | -59% |
| Total assets | SEK 5,7M | +3% |
| Equity | SEK 3,5M | +4% |
| Employees | 1 | — |
Legal name
Dr. Direkt Lallium AB
Org number
5566524434
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
6 december 2003
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten externa firmatecknaren
Company purpose
Bolaget skall tillhandahålla administrativa och finansiella stödtjänster, samt bedriva kapitalförvaltning och därmed förenlig verksamhet.
Address
Östra Hamngatan 52
Phone
+4631424330
Email
foretag@drdirekt.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 014 | 1 419 | 1 627 | 1 601 | 1 646 |
| Staff expenses | — | — | — | — | −63 |
| EBITDA | 49 | 390 | 383 | 381 | 438 |
| Depreciation & amort. | −14 | −16 | −16 | −16 | −16 |
| EBIT | 35 | 374 | 367 | 365 | 423 |
| Net financials | 59 | 554 | 198 | 114 | −110 |
| Profit before tax | 190 | 889 | 504 | 448 | 256 |
| Tax | −49 | −105 | −100 | −113 | −117 |
| Net profit | 141 | 784 | 404 | 335 | 138 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 843 | 4 756 | 5 036 | 5 489 | 5 674 |
| Equity | 2 058 | 2 842 | 3 046 | 3 381 | 3 519 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 129 | 218 | 233 | 290 | 280 |
| Total debt | 129 | 218 | 233 | 290 | 280 |
EBITDA margin
26.6%
This company
15.8%
Market median
+68% vs market
20212025
Equity ratio
62.0%
This company
38.2%
Market median
+62% vs market
20212025
Return on equity
3.9%
This company
18.4%
Market median
-79% vs market
20212025
Net profit margin
8.4%
This company
8.1%
Market median
+4% vs market
20212025
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20212025
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
KG | Audit | 2022 |
DE External Signatory | External Signatory | 2022 |
HM Auditor Substitute | Auditor Substitute | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Direkt Lallium AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kerstin Gunilla Svedberg | Audit | 0 companies |
| David Ernst Molnar | External Signatory | 0 companies |
| Heléne Margareta Ekman | Auditor Substitute | 0 companies |
| Eva Kristina Molnar | Board of Directors | 0 companies |
| Philippe Sebastian Molnar | Deputy Board Member | 0 companies |